APA aipamena

Tehfe, M., Dowden, S., Kennecke, H., El-Maraghi, R., Lesperance, B., Couture, F., . . . Romano, A. (2016). nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial. Adv Ther.

Chicago Style aipamena

Tehfe, Mustapha, Scot Dowden, Hagen Kennecke, Robert El-Maraghi, Bernard Lesperance, Felix Couture, Richard Letourneau, Helen Liu, and Alfredo Romano. "Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial." Adv Ther 2016.

MLA aipamena

Tehfe, Mustapha, et al. "Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial." Adv Ther 2016.